mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-18
DOI
10.3389/fimmu.2021.774103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGK1 in Human Cancer: Emerging Roles and Mechanisms
- (2021) Yiwen Sang et al. Frontiers in Oncology
- The emerging role of miRNA in regulating the mTOR signaling pathway in immune and inflammatory responses
- (2021) Nazanin Nazari et al. IMMUNOLOGY AND CELL BIOLOGY
- Amino acids and RagD potentiate mTORC1 activation in CD8+ T cells to confer antitumor immunity
- (2021) Yiwen Zhang et al. Journal for ImmunoTherapy of Cancer
- Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth
- (2021) Shuwei Guo et al. Stem Cells International
- Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
- (2021) Na Li et al. PeerJ
- Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential
- (2020) Xiangyu Sun et al. Frontiers in Cell and Developmental Biology
- Immunometabolic Interplay in the Tumor Microenvironment
- (2020) Irem Kaymak et al. CANCER CELL
- Research progress of mTOR inhibitors
- (2020) Yifan Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis
- (2019) Sanam Dolati et al. JOURNAL OF NEUROIMMUNOLOGY
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift
- (2019) Jung Eun Park et al. ONCOGENE
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- mTOR Signaling pathway as a master regulator of memory CD8+ T-cells, Th17, and NK cells development and their functional properties
- (2019) Davood Rostamzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer
- (2019) Zhiyong Wang et al. CANCER RESEARCH
- Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
- (2019) Xu-Chao Zhang et al. Nature Communications
- mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment
- (2019) Yu-Li Chen et al. Cancers
- The Prognostic Role of Ribosomal Protein S6 Kinase 1 Pathway in Patients With Solid Tumors: A Meta-Analysis
- (2019) Shuo Zhang et al. Frontiers in Oncology
- Tumour-associated neutrophils in patients with cancer
- (2019) Merav E. Shaul et al. Nature Reviews Clinical Oncology
- Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy
- (2019) Zhongping Yin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells
- (2018) Yuting Deng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex
- (2018) Anastasios Gkountakos et al. CARCINOGENESIS
- M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis
- (2018) Richa Shrivastava et al. CYTOKINE
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+Regulatory T Cells
- (2018) Im-Hong Sun et al. JOURNAL OF IMMUNOLOGY
- Targeting the PI3K pathway in cancer: are we making headway?
- (2018) Filip Janku et al. Nature Reviews Clinical Oncology
- Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E
- (2018) Peiming Zheng et al. Cell Death & Disease
- Phytochemicals as modulators of M1-M2 macrophages in inflammation
- (2018) Uzma Saqib et al. Oncotarget
- MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers
- (2018) Yixin Yang et al. Canadian Journal of Gastroenterology and Hepatology
- Role of mTOR Signaling in Tumor Microenvironment: An Overview
- (2018) Fabiana Conciatori et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MDSC; the Most Important Cell You Have Never Heard Of
- (2018) R.J. Tesi TRENDS IN PHARMACOLOGICAL SCIENCES
- miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer
- (2018) Wei Wang et al. Oncogenesis
- Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
- (2017) Madhav Kishore et al. IMMUNITY
- Modulation of cancer-specific immune responses by amino acid degrading enzymes
- (2017) Elina Timosenko et al. Immunotherapy
- OA06.06 Druggable Alterations Involving Crucial Carcinogenesis Pathways Drive the Prognosis of Squamous Cell Lung Carcinoma (SqCLC)
- (2017) Sara Pilotto et al. Journal of Thoracic Oncology
- CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
- (2017) Jieyao Li et al. OncoImmunology
- Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
- (2017) Susanne M. Steggerda et al. Journal for ImmunoTherapy of Cancer
- Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
- (2017) Seema Gupta et al. Frontiers in Oncology
- T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells
- (2016) Ilaria Marigo et al. CANCER CELL
- mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer
- (2016) David R. Driscoll et al. CANCER RESEARCH
- Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers
- (2016) M. Morrison Joly et al. CANCER RESEARCH
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
- (2016) Roger Geiger et al. CELL
- 4E-BP1, a multifactor regulated multifunctional protein
- (2016) Xiaoyu Qin et al. CELL CYCLE
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
- (2016) Mathias Wenes et al. Cell Metabolism
- Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation
- (2016) Stanley Ching-Cheng Huang et al. IMMUNITY
- Ionic immune suppression within the tumour microenvironment limits T cell effector function
- (2016) Robert Eil et al. NATURE
- Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
- (2016) Thomas Welte et al. NATURE CELL BIOLOGY
- Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression
- (2016) Valerie A Gerriets et al. NATURE IMMUNOLOGY
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis
- (2016) J Musa et al. ONCOGENE
- Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling
- (2016) Di Xie et al. Science China-Life Sciences
- TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
- (2016) Sébastien Viel et al. Science Signaling
- T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy
- (2016) Patrick L. Raber et al. Oncotarget
- Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling
- (2016) Zhao Yang et al. Oncotarget
- Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation
- (2016) Anthony J Covarrubias et al. eLife
- TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
- (2016) Sébastien Viel et al. Science Signaling
- Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8+ effector T cell responses
- (2016) Dàlia Raïch-Regué et al. OncoImmunology
- mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
- (2016) Tingting Wu et al. Scientific Reports
- Elevated Rictor expression is associated with tumor progression and poor prognosis in patients with gastric cancer
- (2015) Yuhai Bian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
- (2015) Ping-Chih Ho et al. CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells
- (2015) John P. Ray et al. IMMUNITY
- Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
- (2015) Abhishek K. Jha et al. IMMUNITY
- Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma
- (2015) Xue-Feng Li et al. JOURNAL OF HEPATOLOGY
- MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression
- (2015) Shiyue Mei et al. PLoS One
- Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance
- (2015) Kenta Masui et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
- (2015) Dorota Klysz et al. Science Signaling
- Control of macrophage metabolism and activation by mTOR and Akt signaling
- (2015) Anthony J. Covarrubias et al. SEMINARS IN IMMUNOLOGY
- RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors
- (2015) H. Cheng et al. Cancer Discovery
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation
- (2015) Guang Yang et al. Cell Reports
- Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
- (2015) Dorota Klysz et al. Science Signaling
- PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
- (2015) S N Payne et al. Oncogenesis
- The mTORC1/S6K1 Pathway Regulates Glutamine Metabolism through the eIF4B-Dependent Control of c-Myc Translation
- (2014) Alfredo Csibi et al. CURRENT BIOLOGY
- Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation
- (2014) Mako Nakaya et al. IMMUNITY
- Cytosolic Branched Chain Aminotransferase (BCATc) Regulates mTORC1 Signaling and Glycolytic Metabolism in CD4+T Cells
- (2014) Elitsa A. Ananieva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of TGF-β Signaling in Generation of CD39+CD73+Myeloid Cells in Tumors
- (2014) Sergey V. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
- (2014) Antoine Marçais et al. NATURE IMMUNOLOGY
- Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function
- (2014) J. Shin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growing knowledge of the mTOR signaling network
- (2014) Kezhen Huang et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity
- (2014) B. C. Grabiner et al. Cancer Discovery
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- Microenvironment and tumor cell plasticity: An easy way out
- (2013) Maria Letizia Taddei et al. CANCER LETTERS
- The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
- (2013) Alfred Csibi et al. CELL
- Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
- (2013) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Rapamycin unbalances the polarization of human macrophages to M1
- (2013) Alessia Mercalli et al. IMMUNOLOGY
- N-myc Downstream-regulated Gene 1 Promotes Tumor Inflammatory Angiogenesis through JNK Activation and Autocrine Loop of Interleukin-1α by Human Gastric Cancer Cells
- (2013) Yuichi Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mammalian Target of Rapamycin Complex 1 (mTORC1) Enhances Bortezomib-induced Death in Tuberous Sclerosis Complex (TSC)-null Cells by a c-MYC-dependent Induction of the Unfolded Protein Response
- (2013) Justin T. Babcock et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
- (2013) Venus Thomanetz et al. JOURNAL OF CELL BIOLOGY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation
- (2013) Linda V Sinclair et al. NATURE IMMUNOLOGY
- mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
- (2013) M. Weiler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-associated macrophages: functional diversity, clinical significance, and open questions
- (2013) Subhra K. Biswas et al. Seminars in Immunopathology
- NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
- (2013) Shin-ichiro Fujii et al. Frontiers in Immunology
- Role of PI3K/Akt signaling in memory CD8 T cell differentiation
- (2013) Eui Ho Kim et al. Frontiers in Immunology
- Regulation of Immune Responses by mTOR
- (2012) Jonathan D. Powell et al. Annual Review of Immunology
- Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer
- (2012) Haiyan Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Macrophage-Induced Tumor Angiogenesis Is Regulated by the TSC2-mTOR Pathway
- (2012) W. Chen et al. CANCER RESEARCH
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
- (2012) Asami Hagiwara et al. Cell Metabolism
- Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice
- (2012) E. Amiel et al. JOURNAL OF IMMUNOLOGY
- PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12
- (2012) Xiaoqing Gan et al. NATURE CELL BIOLOGY
- PI3K-Akt-mTORC1-S6K1/2 Axis Controls Th17 Differentiation by Regulating Gfi1 Expression and Nuclear Translocation of RORγ
- (2012) Yutaka Kurebayashi et al. Cell Reports
- Akt and mTOR in B Cell Activation and Differentiation
- (2012) Jose J. Limon et al. Frontiers in Immunology
- AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
- (2011) Ken Inoki et al. Annual Review of Pharmacology and Toxicology
- Activation of mTORC2 by Association with the Ribosome
- (2011) Vittoria Zinzalla et al. CELL
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
- (2011) Jessica L. Yecies et al. Cell Metabolism
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
- (2011) Greg M Delgoffe et al. NATURE IMMUNOLOGY
- Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGF 1 in Melanoma Enhances Tumor Infiltration and Immunosuppression
- (2010) N. Diaz-Valdes et al. CANCER RESEARCH
- Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial Carcinogenesis
- (2010) Z. H. Lu et al. CANCER RESEARCH
- mTOR Complex Component Rictor Interacts with PKC and Regulates Cancer Cell Metastasis
- (2010) F. Zhang et al. CANCER RESEARCH
- Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1
- (2010) Emmani B.M. Nascimento et al. CELLULAR SIGNALLING
- mTORC2 Regulates Neutrophil Chemotaxis in a cAMP- and RhoA-Dependent Fashion
- (2010) Lunhua Liu et al. DEVELOPMENTAL CELL
- The mTOR Kinase Determines Effector versus Memory CD8 + T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
- (2010) Rajesh R. Rao et al. IMMUNITY
- L-Arginine Deprivation Regulates Cyclin D3 mRNA Stability in Human T Cells by Controlling HuR Expression
- (2010) P. C. Rodriguez et al. JOURNAL OF IMMUNOLOGY
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
- (2010) C A Sparks et al. ONCOGENE
- mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
- (2010) R. J. O. Dowling et al. SCIENCE
- mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
- (2009) David A. Guertin et al. CANCER CELL
- Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
- (2009) P. Gulhati et al. CLINICAL CANCER RESEARCH
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- mTOR regulates memory CD8 T-cell differentiation
- (2009) Koichi Araki et al. NATURE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression
- (2008) Carolyn L. Buller et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
- (2008) Jingxiang Huang et al. BIOCHEMICAL JOURNAL
- Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation
- (2008) M. Wall et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started